steroid-induced-osteoporosis-gets-better-treated-with-teriparatideA recent study has determined that glucocorticoid-induced osteoporosis (OP) is now treatable with a synthetic form of the human parathyroid hormone, Teriparatide.

It was found by the researchers that patients with glucocorticoid-induced OP and administered with teriparatide for 36 months had a greater increase in bone mineral density (BMD) and fewer new vertebral fractures than those treated with alendronate.

The findings of this study are published in the November issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR).